The vast majority of Mesothelioma cases are caused by exposure to asbestos in the workplace or at home. This is a common statement put forth about the cancer, but you’ll note it doesn’t state that all cases are caused by asbestos exposure. There are instances where asbestos is not involved. One that is garnering attention is whether the SV-40 Virus might cause it.

SV-40 stands for Simiun Virus 40, which is to say it is derived from monkeys. How did this virus become a concern to humans? Well, polio was once a huge health problem. A vaccine was developed for it that has largely eradicated the disease. Oh, there was one small problem. The vaccine was grown on monkey kidneys. Some of the monkeys had contracted SV-40. While not impacting the effectiveness of the vaccine, the virus did travel along with it into some human hosts.

So, what’s the big deal? Well, Mesothelioma is a hotly researched form of cancer. One of the methods of studying it is to look at the tumors it produces. In doing so, researches started discovering something very odd. SV-40 was being found in Mesothelioma cancer growths where the patient reported no exposure to asbestos at any point in their life. Researchers started to question whether the virus could be a cause of the cancer in the absence of any asbestos exposure. Continue reading ‘Mesothelioma – Can The SV-40 Virus Cause It?’ »

Every country has it’s a cancer society that basically is a health organization with a sole aim to bring awareness about the fatal disease, prevention, treatment and social impact. A few of these are:

American cancer society (ACS)

It is a nationwide organization where dedicated individuals work on voluntary basis for the purpose of eradicating cancer. They are helping the community through:

* Research
* Education
* Medical aid
* Advocacy
* Related services Continue reading ‘Cancer Society’ »

EASD 2009: Lantus defended amid allegations of increased cancer risk

It presenters at the conference discussed the current evidence and its limitations. However, a potential mechanism by which insulin could promote cancer cell growth was also proposed. ( http://www.bharatbook.com/detail.asp?id=91847&rt=Commercial-Insight-Cardiovascular-and-Metabolic-Market-Overview-Diabetes-to-the-fore-as-generics-hit-primary-care-markets.html )

Although the European Association for the Study of Diabetes (EASD) recommended the continued use of Lantus in type 1 and type 2 diabetics, it has called for increased research into the relationship between insulin therapy – particularly Lantus (insulin glargine; Sanofi-Aventis) – and the risk of cancer.

It was postulated during the discussion at the 2009 EASD meeting that insulin use may be related to the increased incidence of cancer seen in diabetics over that seen in the general population. The preliminary data discussed in the symposium suggested lower rates of cancer with Levemir (insulin detemir; Novo Nordisk) compared to neutral protamine Hagedorn (NPH), but higher rates with Lantus. Continue reading ‘EASD 2009 – Lantus defended amid allegations of increased cancer risk’ »

Liver Cancer – Drug Pipeline Analysis and Market Forecasts to 2016

This is an essential source of information and analysis on the global liver cancer market. The report identifies the key trends shaping and driving the global liver cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global liver cancer sector. ( http://www.bharatbook.com/detail.asp?id=134332&rt=Liver-Cancer-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html ) Continue reading ‘Liver Cancer Market Is Very Strong With Clinical Development’ »

Incoming search terms:

• Miripla

There has always been a cure for cancer but our doctors and research scientists don’t know about it. The cure is exactly the same as its prevention, which is a lifestyle that enhances the immune system. So why aren’t we told this or why are we still searching for a cure? It’s because profit plays a huge role in all western medicine whereas nature cannot be patented so there’s no profit in conducting studies on natural remedies for cancer. The potential as a money-maker using a drug to cure cancer is enormous and that’s why they are still looking.

Cancer is a deficiency disease where the body has been weakened by the way we live with our wrong food choices, our sedentary lifestyle and other factors and there isn’t a drug to cure that problem. There are only natural ways to achieve that by correcting the factors that first caused it. That’s why they haven’t been able to find a cure for cancer because what they are looking for doesn’t exist.

This is history repeating itself. In the last 2 or 3 hundred years there have been diseases such as scurvy, pellagra, pernicious anaemia and rickets which are also deficiency diseases and it took decades for doctors to realize this. Even when the causes were found they were very slow in implementing the changes necessary to bring these diseases under control. Continue reading ‘We Already Have A Cure For Cancer So Why Are We Still Funding Research’ »

Incoming search terms:

• testimonies of women cured stage 2 cervical cancer without surgery
• we have a cure for cancer
• why is funding for cure cancer so hard

Oncology Market Leaders – Analyses and Outlook – 2010-2025

Cancer treatment is a global healthcare priority, one with rising therapeutic and commercial importance. Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in 2008 (WHO). Furthermore, anti-cancer drug sales exceeded $50bn worldwide in 2009. The oncology drug market has grown impressively, driven by rising disease prevalence, expanding patient populations and technological advances, especially in biomolecular medicine. Current treatments are better-tolerated, more- effective and more-commercially-successful than ever before, our latest report shows. ( http://www.bharatbook.com/detail.asp?id=132312&rt=Oncology-Market-Leaders-Analyses-and-Outlook-2010-2025.html )

The aging of populations, lifestyle changes in the developing world, together with significant advances in pharmacotherapy and diagnostics, will drive the cancer treatments market from 2010 onwards. Increasing disease prevalence and a strong R&D pipeline make the anti-cancer sector dynamic and highly promising for pharmaceutical and biotechnology companies worldwide. Our new report, Oncology Market Leaders – Analyses and Outlook – 2010-2025, explains why and to what extent, revealing where the most-exciting and lucrative developments will lie from 2010 onwards. There, you will find detailed sales predictions and supporting discussions. Continue reading ‘Comprehensive Analysis Of The Oncology Market Sector’ »

Incoming search terms:

• global cancer market review

Cancer Head and Neck Cancer Therapy Area Pipeline Report

This report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. ( http://www.bharatbook.com/detail.asp?id=126756&rt=Cancer-Head-and-Neck-Cancer-Therapy-Area-Pipeline-Report.html )

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Continue reading ‘Cancer Head And Neck Cancer Therapy Area Pipeline Report’ »

Breast cancer is the second most common type of cancer after lung cancer worldwide and the fifth most common cause of cancer death. It is found more in women as compared to men. Worldwide more than one million new cases of breast cancer are found every year. New breast cancer cases are mostly found in North America.

Breast cancer is usually found in women over the age of 40 years. Breast cancer cases have risen about 30% in the past 25 years in western countries like the US and Europe. Breast cancer market is comprised of two segments – diagnostic and therapy. The key drivers of breast cancer market are aging population, obesity and family history among others. Continue reading ‘New Report “breast Cancer Market – An Analysis” Available Through Aarkstore Enterprise’ »